0001193805-24-000333.txt : 20240307 0001193805-24-000333.hdr.sgml : 20240307 20240307160331 ACCESSION NUMBER: 0001193805-24-000333 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240305 FILED AS OF DATE: 20240307 DATE AS OF CHANGE: 20240307 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Green James W CENTRAL INDEX KEY: 0001400121 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33957 FILM NUMBER: 24729978 MAIL ADDRESS: STREET 1: 12525 CHADRON AVENUE CITY: HAWTHORNE STATE: CA ZIP: 90250 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HARVARD BIOSCIENCE INC CENTRAL INDEX KEY: 0001123494 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 043306140 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 84 OCTOBER HILL RD CITY: HOLLISTON STATE: MA ZIP: 01746 BUSINESS PHONE: 5088938999 MAIL ADDRESS: STREET 1: 84 OCTOBER HILL ROAD CITY: HOLLISTON STATE: MA ZIP: 01746 4 1 e619331_4-green.xml X0508 4 2024-03-05 0 0001123494 HARVARD BIOSCIENCE INC HBIO 0001400121 Green James W C/O HARVARD BIOSCIENCE, INC. 84 OCTOBER HILL ROAD HOLLISTON MA 01746 1 1 0 0 Chief Executive Officer 0 Common Stock 2024-03-05 4 A 0 214797 0.00 A 2866294 D Common Stock 2024-03-05 4 A 0 214797 0.00 A 3081091 D Represents an award of restricted stock units ("RSUs") that will vest in three equal installments on March 19, 2025, 2026, and 2027. The number of RSUs represents the target number of RSUs that may be earned based on achievement by the Company of certain performance criteria. The actual number of RSUs awarded may vary between 0% and 150% of the target, depending on the Company's performance. The performance period will end on December 31, 2026. Includes (a) the awards described in footnotes (1) and (2) above, (b) 235,427 RSUs that will vest in two equal installments on December 29, 2024 and 2025, (c) 52,346 RSUs that will vest on December 29, 2024, (d) 484,975 RSUs with performance based vesting conditions tied to relative total shareholder return and (e) 1,878,749 shares of common stock beneficially owned by the Reporting Person. /s/ David Sirois, by power of attorney 2024-03-07